Radius Health, Inc.

Pages

Radius Health, Inc.

$RDUS

Search Table
Pages

Trade Date Insider Title Buy or Sell Quantity Security Type Price Proceeds Transaction Conviction Position Quantity Position Value Positon Conviction SEC Link Nature of Ownership
2020-07-08Biotech Target N V-Buy25,000Common Stock$13.21-$330,250.00  5.39     [ Very High ]6,956,685$91,897,808.85  1,499.64 [Very High]Form 4-
2020-04-30Biotech Target N V-Buy50,000Common Stock$15.75-$787,500.00  10.78    [ Very High ]6,931,685$109,174,038.75  1,494.25 [Very High]Form 4-
2020-09-11Biotech Target N V-Buy199,029Common Stock$11.33-$2,254,998.57  42.83    [ Very High ]7,155,714$81,074,239.62  1,539.79 [Very High]Form 4-
2020-09-14Biotech Target N V-Buy200,000Common Stock$11.69-$2,338,000.00  43.04    [ Very High ]7,355,714$85,988,296.66  1,582.83 [Very High]Form 4-
2020-11-05Biotech Target N V-Buy100,000Common Stock$14.26-$1,426,000.00  21.48    [ Very High ]7,455,714$106,318,481.64  1,601.76 [Very High]Form 4-
2021-02-22Jean Pierre Garnier-Buy5,500Common Stock$0.00$0.00  -21,300$0.00  4.58     [Low]Form 4-
2021-02-22Willard H Dere-Buy5,500Common Stock$0.00$0.00  -17,695$0.00  3.80     [Low]Form 4-
2021-02-22Cathy Friedman-Buy5,500Common Stock$0.00$0.00  -21,300$0.00  4.58     [Low]Form 4-
2021-02-22Owen Hughes-Buy5,500Common Stock$0.00$0.00  -16,150$0.00  3.47     [Low]Form 4-
2021-02-22Sean Murphy-Buy5,500Common Stock$0.00$0.00  -5,500$0.00  1.18     [Very Low]Form 4-
2021-02-25Sal GraussoChief Commercial OfficerSell1,322Common Stock$18.93$25,025.46  0.28     [ Low ]11,709$221,651.37  2.52     [Low]Form 4-
2021-03-05James George ChopasPrincipal Finance AccountingSell370Common Stock$20.88$7,725.60  0.08     [ Very Low ]6,701$139,916.88  1.43     [Low]Form 4-
2021-08-24Steven HelwigPrincipal Financial OfficerBuy5,125Common$0.00$0.00  -20,829$0.00  4.41     [Low]Form 4-
2021-05-17Chhaya ShahChief Business OfficerBuy10,000Common Stock$0.00$0.00  -29,645$0.00  6.27     [Average]Form 4-
2021-09-22Biotech Target N V-Buy150,000Common Stock$12.28-$1,842,000.00  31.74    [ Very High ]7,605,714$93,398,167.92  1,609.13 [Very High]Form 4-
2021-09-29Biotech Target N V-Buy100,000Common Stock$12.95-$1,295,000.00  21.16    [ Very High ]7,705,714$99,788,996.30  1,630.29 [Very High]Form 4-
2021-12-08Rubric Capital Management Lp-Buy560,691Common Stock, par value $0.0001 per share ("Common Stock")$8.02-$4,496,741.82  118.43   [ Very High ]5,317,567$42,646,887.34  1,123.22 [Very High]Form 4See footnote
2021-12-09Rubric Capital Management Lp-Buy264,644Common Stock$7.58-$2,006,001.52  55.90    [ Very High ]5,582,211$42,313,159.38  1,179.12 [Very High]Form 4See footnote
2021-12-10Rubric Capital Management Lp-Buy768,171Common Stock$7.17-$5,507,786.07  162.26   [ Very High ]6,350,382$45,532,238.94  1,341.38 [Very High]Form 4See footnote
2021-12-13Rubric Capital Management Lp-Buy187,391Common Stock, par value $0.0001 per share ("Common Stock")$7.08-$1,326,728.28  39.58    [ Very High ]6,537,773$46,287,432.84  1,380.97 [Very High]Form 4See footnote
2021-12-14Rubric Capital Management Lp-Buy94,103Common Stock$6.81-$640,841.43  19.88    [ Very High ]6,631,876$45,163,075.56  1,400.84 [Very High]Form 4See footnote
2021-12-15Rubric Capital Management Lp-Buy180,744Common Stock$6.77-$1,223,636.88  38.18    [ Very High ]6,812,620$46,121,437.40  1,439.02 [Very High]Form 4See footnote
2021-12-16Rubric Capital Management Lp-Buy146,685Common Stock, par value $0.0001 per share ("Common Stock")$7.07-$1,037,062.95  30.98    [ Very High ]6,959,305$49,202,286.35  1,470.01 [Very High]Form 4See footnote
2022-01-05Biotech Target N V-Buy250,000Common Stock$6.30-$1,575,000.00  52.81    [ Very High ]7,955,714$50,120,998.20  1,680.48 [Very High]Form 4-
2022-01-06Biotech Target N V-Buy300,000Common Stock$6.31-$1,893,000.00  63.37    [ Very High ]8,255,714$52,093,555.34  1,743.85 [Very High]Form 4-
2022-01-14Jean Pierre Garnier-Buy5,500Common Stock$0.00$0.00  -26,800$0.00  5.66     [Average]Form 4-
2022-01-14Willard H Dere-Buy5,500Common Stock$0.00$0.00  -23,195$0.00  4.90     [Average]Form 4-
2022-01-14Cathy Friedman-Buy5,500Common Stock$0.00$0.00  -26,800$0.00  5.66     [Average]Form 4-
2022-01-14Danielle HoltschlagVice President, SalesBuy25,000Common Stock$0.00$0.00  -25,000$0.00  5.28     [Average]Form 4-
2022-01-14Sean Murphy-Buy5,500Common Stock$0.00$0.00  -11,000$0.00  2.32     [Low]Form 4-
2022-01-14Steven HelwigPrincipal Financial OfficerBuy15,000Common Stock$0.00$0.00  -31,251$0.00  6.60     [Average]Form 4-
2022-01-14Owen Hughes-Buy5,500Common Stock$0.00$0.00  -21,650$0.00  4.57     [Low]Form 4-
2022-01-14Machelle Sanders-Buy5,500Common Stock$0.00$0.00  -5,500$0.00  1.16     [Very Low]Form 4-
2022-01-14Von Eschenbach Andrew C.-Buy5,500Common Stock$0.00$0.00  -5,500$0.00  1.16     [Very Low]Form 4-
2022-01-14Chhaya ShahChief Business OfficerBuy65,000Common Stock$0.00$0.00  -94,645$0.00  19.99    [High]Form 4-
2022-02-21G. Kelly MartinCEO and PresidentBuy960,000Common Stock$0.00$0.00  -960,000$0.00  202.78   [Very High]Form 4-
2022-02-21G. Kelly MartinCEO and PresidentBuy75,000Common Stock$0.00$0.00  -75,000$0.00  15.84    [High]Form 4-
2022-03-15Mark William ConleyVP, Chief Financial OfficerBuy50,000Common Stock$0.00$0.00  -50,000$0.00  10.56    [Average]Form 4-
2022-05-18Biotech Target N V-Buy477,824Common Stock$5.57-$2,661,479.68  100.45   [ Very High ]8,733,538$48,645,806.66  1,835.93 [Very High]Form 4-